31 Mar 2020
Assets6.39
Total Income5.01
Profit After Tax-0.80
NET Worth-3.00
At a glance
Updated 2026-09-17The shares listed at ₹105.00, a 3.96% move from the issue price. Trident Lifeline is a SME IPO with an issue size of ₹35.34 crore, proposed for listing on BSE SME. The offer opens on 26th Sep 2022 and closes on 29th Sep 2022. The issue structure includes a fresh issue of ₹33.57 crore. The current listing schedule points to 10th Oct 2022.
Issue details
Listing atBSE SME
Issue typeFixed Price Issue
Issue size₹35.34 Cr
Fresh issue₹33.57 Cr
Face value₹10
Price band—–—
Allotment4th Oct 2022
Listing10th Oct 2022
Listing performance
Full performance ↗Issue price₹101.00
Listing price₹105.00
Current price—
Listing gain3.96%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹2.00
GMP / upper priceNO DATA
Est. listing₹103.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens26th Sep 2022
Closes29th Sep 2022
Allotment4th Oct 2022
Refund6th Oct 2022
Demat7th Oct 2022
Listing10th Oct 2022
Subscription demand
Full bidding ↗Total1.34×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 1200 | — |
Company
Incorporated2014
Use of proceeds
| Object | Amount |
|---|---|
| To Meet Working Capital Requirements | ₹20.50 Cr |
| Product registration in the International Markets | ₹5.14 Cr |
| General Corporate Purpose | ₹6.71 Cr |
| Public Issue Expenses | ₹3.00 Cr |
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue22.37₹ Cr · +128.7% vs prior year
PAT2.27₹ Cr · +260.3% vs prior year
Assets13.86₹ Cr · +21.2% vs prior year
Net Worth4.80₹ Cr · +1,121.3% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2021
Assets11.44
Total Income9.78
Profit After Tax0.63
NET Worth-0.47
31 Mar 2022
Assets13.86
Total Income22.37
Profit After Tax2.27
NET Worth4.80
KPIs
| KPI |
|---|
| RoNW |
Valuation & shareholding
Pre-IPO EPS3.98
Pre-IPO P/E51.53
Promoter holding pre100%
Promoter holding post69.57%
Market cap₹116.14 Cr.
Peer comparison
| Company | EPS | P/E | RoNW | NAV |
|---|---|---|---|---|
| Trident Lifeline IPO | — | 51.53 x | — | — |
| Bio Medica IPO | — | 13.45 x | — | — |
| Goldline Pharmaceutical IPO | — | 14.56 x | — | — |
| Speciality Medicines IPO | — | 10.49 x | — | — |
Issue expenses
| Expense | Amount |
|---|---|
| To Meet Working Capital Requirements | ₹20.50 Cr |
| Product registration in the International Markets | ₹5.14 Cr |
| General Corporate Purpose | ₹6.71 Cr |
| Public Issue Expenses | ₹3.00 Cr |
Registrar & lead managers
Registrar
MUFG Intime India Pvt.Ltd.Lead managers
- Beeline Capital Advisors Pvt.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-09-17.
IPO UPDATE ALERTS
Register for IPO Updates →Track Trident Lifeline without missing an update
Register for subscription, GMP, allotment and listing notifications.